PMV Pharmaceuticals (PMVP) Change in Account Payables (2019 - 2026)

PMV Pharmaceuticals (PMVP) has 8 years of Change in Account Payables data on file, last reported at -$1.5 million in Q1 2026.

• Quarterly Change in Account Payables rose 48.96% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 171.61% YoY) and the FY2025 annual result came in at -$3.4 million, down 202.45% from the prior year.
• Change in Account Payables slipped to -$1.5 million in Q1 2026, from -$244000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $4.5 million in Q4 2024 to a low of -$3.0 million in Q1 2025.
• A 5-year average of -$103529.4 and a median of -$995000.0 in 2025 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2022 — Change in Account Payables jumped 292.59% — and 2023, when it sank 735.98%.
• Tracing PMVP's Change in Account Payables over 5 years: stood at -$1.3 million in 2022, then soared by 223.65% to $1.6 million in 2023, then surged by 190.79% to $4.5 million in 2024, then plunged by 105.4% to -$244000.0 in 2025, then sank by 524.59% to -$1.5 million in 2026.
• The last three Change in Account Payables figures came in at -$1.5 million (Q1 2026), -$244000.0 (Q4 2025), and $801000.0 (Q3 2025), per Business Quant data.